Trial Profile
A Comparison of Platelet Inhibition Following a Prasugrel 60 mg or Prasugrel 30 mg Loading Dose With or Without Pretreatment With a Clopidogrel Loading Dose in Acute Coronary Syndrome Patients Who Are to Undergo Percutaneous Coronary Intervention.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Embolism and thrombosis; Myocardial infarction; Unstable angina pectoris
- Focus Pharmacodynamics
- Acronyms TRIPLET
- Sponsors Eli Lilly and Company
- 09 May 2012 Official Title amended as reported by Clinical Trials Registry - India record.
- 19 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2011 Planned end date changed from 1 Sep 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.